628 related articles for article (PubMed ID: 19132785)
41. Ro(SSA) and La(SSB) antibodies in the clinical spectrum of Sjögren's syndrome.
Alexander EL; Hirsch TJ; Arnett FC; Provost TT; Stevens MB
J Rheumatol; 1982; 9(2):239-46. PubMed ID: 7097683
[TBL] [Abstract][Full Text] [Related]
42. Antibodies against mutated citrullinated vimentin are a better predictor of disease activity at 24 months in early rheumatoid arthritis than antibodies against cyclic citrullinated peptides.
Innala L; Kokkonen H; Eriksson C; Jidell E; Berglin E; Dahlqvst SR
J Rheumatol; 2008 Jun; 35(6):1002-8. PubMed ID: 18398946
[TBL] [Abstract][Full Text] [Related]
43. Genetic background of anticyclic citrullinated peptide autoantibody production in Hungarian patients with rheumatoid arthritis.
Poór G; Nagy ZB; Schmidt Z; Brózik M; Merétey K; Gergely P
Ann N Y Acad Sci; 2007 Sep; 1110():23-32. PubMed ID: 17911417
[TBL] [Abstract][Full Text] [Related]
44. Systemic autoimmune diseases in patients with hepatitis C virus infection: characterization of 1020 cases (The HISPAMEC Registry).
Ramos-Casals M; Muñoz S; Medina F; Jara LJ; Rosas J; Calvo-Alen J; Brito-Zerón P; Forns X; Sánchez-Tapias JM;
J Rheumatol; 2009 Jul; 36(7):1442-8. PubMed ID: 19369460
[TBL] [Abstract][Full Text] [Related]
45. Characteristics of Sjögren's syndrome in rheumatoid arthritis.
He J; Ding Y; Feng M; Guo J; Sun X; Zhao J; Yu D; Li Z
Rheumatology (Oxford); 2013 Jun; 52(6):1084-9. PubMed ID: 23382356
[TBL] [Abstract][Full Text] [Related]
46. [Comparison and relevance of rheumatoid factors, antikeratin antibodies and anti-cyclic citrullinated peptides antibodies in rheumatoid arthritis].
Galati S; Beauvillain C; Renier G; Jeannin P; Masson C; Chevailler A
Ann Biol Clin (Paris); 2008; 66(2):157-64. PubMed ID: 18390426
[TBL] [Abstract][Full Text] [Related]
47. Antiagalactosyl IgG antibodies in juvenile idiopathic arthritis, juvenile onset Sjögren's syndrome, and healthy children.
Maeno N; Takei S; Fujikawa S; Yamada Y; Imanaka H; Hokonohara M; Kawano Y; Oda H
J Rheumatol; 2004 Jun; 31(6):1211-7. PubMed ID: 15170938
[TBL] [Abstract][Full Text] [Related]
48. Rheumatoid factor and antibodies to cyclic citrullinated peptides are associated with severe extra-articular manifestations in rheumatoid arthritis.
Turesson C; Jacobsson LT; Sturfelt G; Matteson EL; Mathsson L; Rönnelid J
Ann Rheum Dis; 2007 Jan; 66(1):59-64. PubMed ID: 16901955
[TBL] [Abstract][Full Text] [Related]
49. Precocious intima-media thickening in patients with primary Sjögren's syndrome.
Vaudo G; Bocci EB; Shoenfeld Y; Schillaci G; Wu R; Del Papa N; Vitali C; Delle Monache F; Marchesi S; Mannarino E; Gerli R
Arthritis Rheum; 2005 Dec; 52(12):3890-7. PubMed ID: 16320337
[TBL] [Abstract][Full Text] [Related]
50. The role of anti-mutated citrullinated vimentin antibodies in the diagnosis of early rheumatoid arthritis.
Liu X; Jia R; Zhao J; Li Z
J Rheumatol; 2009 Jun; 36(6):1136-42. PubMed ID: 19447936
[TBL] [Abstract][Full Text] [Related]
51. Anticentromere antibodies identify patients with Sjögren's syndrome and autoimmune overlap syndrome.
Salliot C; Gottenberg JE; Bengoufa D; Desmoulins F; Miceli-Richard C; Mariette X
J Rheumatol; 2007 Nov; 34(11):2253-8. PubMed ID: 17937465
[TBL] [Abstract][Full Text] [Related]
52. Prevalence and significance of anti-peptidylarginine deiminase 4 antibodies in rheumatoid arthritis.
Zhao J; Zhao Y; He J; Jia R; Li Z
J Rheumatol; 2008 Jun; 35(6):969-74. PubMed ID: 18398945
[TBL] [Abstract][Full Text] [Related]
53. Insights to clinical use of serial determination in titers of cyclic citrullinated peptide autoantibodies.
Kogure T; Tatsumi T; Fujinaga H; Niizawa A; Terasawa K
Mediators Inflamm; 2007; 2007():12367. PubMed ID: 17497027
[TBL] [Abstract][Full Text] [Related]
54. Autoantibodies against alpha-fodrin in Sjögren's syndrome with neurological manifestations.
de Seze J; Dubucquoi S; Fauchais AL; Hachulla E; Matthias T; Lefranc D; Hatron PY; Vermersch P; Witte T
J Rheumatol; 2004 Mar; 31(3):500-3. PubMed ID: 14994394
[TBL] [Abstract][Full Text] [Related]
55. IgM-rheumatoid factor, anti-cyclic citrullinated peptide, and anti-citrullinated human fibrinogen antibodies decrease during treatment with the tumor necrosis factor blocker infliximab in patients with rheumatoid arthritis.
Vis M; Bos WH; Wolbink G; Voskuyl AE; Twisk JW; Van de Stadt R; Hamann D; Dijkmans BA; Lems WF
J Rheumatol; 2008 Mar; 35(3):425-8. PubMed ID: 18322974
[TBL] [Abstract][Full Text] [Related]
56. Assessment of SS-A and SS-B in parotid saliva of patients with Sjögren's syndrome.
Hammi AR; Al-Hashimi IH; Nunn ME; Zipp M
J Oral Pathol Med; 2005 Apr; 34(4):198-203. PubMed ID: 15752253
[TBL] [Abstract][Full Text] [Related]
57. Hepatitis C virus infection and primary Sjögren's syndrome: a clinical and serologic description of 9 patients.
Ceribelli A; Cavazzana I; Cattaneo R; Franceschini F
Autoimmun Rev; 2008 Dec; 8(2):92-4. PubMed ID: 18692602
[TBL] [Abstract][Full Text] [Related]
58. Anti-agalactosyl IgG antibodies and isotype profiles of rheumatoid factors in Sjögren's syndrome and rheumatoid arthritis.
Ichikawa Y; Yamada C; Horiki T; Hoshina Y; Uchiyama M; Yamada Y; Toumatu J
Clin Exp Rheumatol; 1998; 16(6):709-15. PubMed ID: 9844764
[TBL] [Abstract][Full Text] [Related]
59. Prevalence and characteristics of Sjögren's syndrome or Sicca syndrome in chronic hepatitis C virus infection: a prospective study.
Loustaud-Ratti V; Riche A; Liozon E; Labrousse F; Soria P; Rogez S; Babany G; Delaire L; Denis F; Vidal E
J Rheumatol; 2001 Oct; 28(10):2245-51. PubMed ID: 11669164
[TBL] [Abstract][Full Text] [Related]
60. Relation of systemic autoantibodies to the number of extraglandular manifestations in primary Sjögren's Syndrome: a retrospective analysis of 65 patients in the Netherlands.
ter Borg EJ; Risselada AP; Kelder JC
Semin Arthritis Rheum; 2011 Jun; 40(6):547-51. PubMed ID: 20864144
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
